β3-AR and the vertebrate heart: A comparative view

Acta Physiologica

Volumn 214, Issue 2, 2015, Pages 158-175

  Imbrogno, S ^a   Gattuso, A ^a   Mazza, R ^a   Angelone, T ^a,b   Cerra, M C ^a,b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b National Institute for Cardiovascular Research   (Italy)

Author keywords

Adrenergic receptors; Amphibians; Cardiac performance; Mammals; Nitric oxide; Teleosts

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; NITRIC OXIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

AMPHIBIA; CARDIOVASCULAR DISEASE; ENDOCARDIUM; ENDOTHELIUM; FISH; HEART; HEART FUNCTION; HUMAN; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TELEOST; VERTEBRATE; ANIMAL; COMPARATIVE STUDY; METABOLISM; PHYSIOLOGY;

ADRENERGIC BETA-AGONISTS; ANIMALS; HEART; HUMANS; NITRIC OXIDE; RECEPTORS, ADRENERGIC, BETA-3; SIGNAL TRANSDUCTION; VERTEBRATES;

EID: 84929292063     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12493     Document Type: Review

References (147)

1. Angelone, T., Filice, E., Quintieri, A.M., Imbrogno, S., Recchia, A., Pulerà, E., Mannarino, C., Pellegrino, D. & Cerra, M.C. 2008. Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway. Acta Physiol (Oxf) 193, 229-239.
2. Angelone, T., Mazza, R. & Cerra, M.C. 2012a. Chromogranin-A: a multifaceted cardiovascular role in health and disease. Curr Med Chem 19, 4042-4050.
3. Angelone, T., Quintieri, A.M., Pasqua, T., Gentile, S., Tota, B., Mahata, S.K. & Cerra, M.C. 2012b. Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin. Am J Physiol Heart Circ Physiol 302, H431-H442.
4. Aragón, J.P., Condit, M.E., Bhushan, S., Predmore, B.L., Patel, S.S., Grinsfelder, D.B., Gundewar, S., Jha, S., Calvert, J.W., Barouch, L.A., Lavu, M., Wright, H.M. & Lefer, D.J. 2011. Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. J Am Coll Cardiol 58, 2683-2691.
5. Arch, J.R. & Kaumann, A.J. 1993. Beta 3 and atypical beta-adrenoceptors. Med Res Rev 13, 663-729.
6. Arch, J.R. & Wilson, S. 1996. Beta 3-adrenoceptors and the regulation of metabolism in adipose tissues. Biochem Soc Trans 24, 412-418.
7. Ask, J.A. 1983. Comparative aspects of adrenergic receptors in the hearts of lower vertebrates. Comp Biochem Physiol A Physiol 76, 543-552.
8. Audigane, L., Kerfant, B.G., El Harchi, A., Lorenzen-Schmidt, I., Toumaniantz, G., Cantereau, A., Potreau, D., Charpentier, F., Noireaud, J. & Gauthier, C. 2009. Rabbit, a relevant model for the study of cardiac beta 3-adrenoceptors. Exp Physiol 94, 400-411.
9. Axelsson, M. 1988. The importance of nervous and humoral mechanisms in the control of cardiac performance in the Atlantic cod Gadus morhua at rest and during non-exhaustive exercise. J Exp Biol 137, 287-301.
10. Axelsson, M., Ehrenström, F. & Nilsson, S. 1987. Cholinergic and adrenergic influence on the teleost heart in vivo. Exp Biol 46, 179-186.
11. Baker, J.G. 2010. A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors. PLoS ONE 5, e15487.
12. Balligand, J.L. 2000. The beta 3-adrenoceptor: physiological role and potential therapeutic applications. Acta Clin Belg 55, 209-214.
13. Balligand, J.L. 2009. Beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?". J Am Coll Cardiol 53, 1539-1542.
14. Balligand, J.L. 2013. Beta3-adrenoreceptors in cardiovascular diseases: new roles for an "old" receptor. Curr Drug Deliv 10, 64-66.
15. Bardou, M., Loustalot, C., Cortijo, J., Simon, B., Naline, E., Dumas, M., Esteve, S., Croci, T., Chalon, P., Frydman, R., Sagot, P., Manara, L., Morcillo, E.J. & Advenier, C. 2000. Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium. Br J Pharmacol 130, 1960-1966.
16. Belge, C., Hammond, J., Dubois-Deruy, E., Manoury, B., Hamelet, J., Beauloye, C., Markl, A., Pouleur, A.C., Bertrand, L., Esfahani, H. et al. 2014. Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase. Circulation 129, 451-462.
17. Bellantuono, V., Cassano, G. & Lippe, C. 2008. The adrenergic receptor subtypes present in frog (Rana esculenta) skin. Comp Biochem Physiol C Toxicol Pharmacol 148, 160-164.
18. Berg, T., Piercey, B.W. & Jensen, J. 2010. Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats. Hypertension 55, 1224-1230.
19. Boivin, B., Lavoie, C., Vaniotis, G., Baragli, A., Villeneuve, L.R., Ethier, N., Trieu, P., Allen, B.G. & Hébert, T.E. 2006. Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc Res 7, 69-78.
20. Brixius, K., Bloch, W., Ziskoven, C., Bolck, B., Napp, A., Pott, C., Steinritz, D., Jiminez, M., Addicks, K., Giacobino, J.P. & Schwinger, R.H. 2006. Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium. Can J Physiol Pharmacol 84, 1051-1060.
21. Brodde, O.E. 1991. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43, 203-242.
22. + pump by reversal of an inhibitory oxidative modification. Circulation 122, 2699-2708.
23. Calvert, J.W. & Lefer, D.J. 2013. Role of β-adrenergic receptors and nitric oxide signaling in exercise-mediated cardioprotection. Physiology 28, 216-224.
24. Campbell, D.L., Giles, W.R., Hume, J.R. & Shibata, E.F. 1988. Inactivation of calcium current in bull-frog atrial myocytes. J Physiol 403, 287-315.
25. Candelore, M.R., Deng, L., Tota, L., Guan, X.M., Amend, A., Liu, Y., Newbold, R., Cascieri, M.A. & Weber, A.E. 1999. Potent and selective human beta(3)-adrenergic receptor antagonists. J Pharmacol Exp Ther 290, 649-655.
26. Cano-Martínez, A., Vargas-González, A., Guarner-Lans, V. & Prado-Zayago, E. 2004. Isoproterenol-produced damage in amphibian heart could be mediated by adrenergic receptors located in the heart muscle. Proc West Pharmacol Soc 47, 63-66.
27. Cerra, M.C. & Imbrogno, S. 2012. Phospholamban and cardiac function: a comparative perspective in vertebrates. Acta Physiol (Oxf) 205, 9-25.
28. Chamberlain, P.D., Jennings, K.H., Paul, F., Cordell, J., Berry, A., Holmes, S.D., Park, J., Chambers, J., Sennitt, M.V., Stock, M.J., Cawthorne, M.A., Young, P.W. & Murphy, G.J. 1999. The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 23, 1057-1065.
29. Cheng, H.J., Zhang, Z.S., Onishi, K., Ukai, T., Sane, D.C. & Cheng, C.P. 2001. Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium. Circ Res 89, 599-606.
30. 3-adrenoceptor activation increases force and Ca(2 + ) current at physiological temperature. Br J Pharmacol 162, 823-839.
31. Cohen, M.L., Bloomquist, W., Kriauciunas, A., Shuker, A. & Calligaro, D. 1999. Aryl propanolamines: comparison of activity at human beta3 receptors, rat beta3 receptors and rat atrial receptors mediating tachycardia. Br J Pharmacol 126, 1018-1024.
32. Damy, T., Ratajczak, P., Robidel, E., Bendall, J.K., Oliviéro, P., Boczkowski, J., Ebrahimian, T., Marotte, F., Samuel, J.L. & Heymes, C. 2003. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J 17, 1934-1936.
33. Damy, T., Ratajczak, P., Shah, A.M., Camors, E., Marty, I., Hasenfuss, G., Marotte, F., Samuel, J.L. & Heymes, C. 2004. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363, 1365-1367.
34. Dashow, L. & Epple, A. 1985. Plasma catecholamines in the lamprey: intrinsic cardiovascular messengers? Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 82, 119-122.
35. De Matteis, R., Arch, J.R., Petroni, M.L., Ferrari, D., Cinti, S. & Stock, M.J. 2002. Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 26, 1442-1450.
36. Dessy, C. & Balligand, J.L. 2010. Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Adv Pharmacol 59, 135-163.
37. Dessy, C., Moniotte, S., Ghisdal, P., Havaux, X., Noirhomme, P. & Balligand, J.L. 2004. Endothelial β3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation 110, 948-954.
38. Dessy, C., Saliez, J., Ghisdal, P., Daneau, G., Lobysheva, I.I., Frérart, F., Belge, C., Jnaoui, K., Noirhomme, P., Feron, O. & Balligand, J.L. 2005. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation betablocker nebivolol. Circulation 112, 1198-1205.
39. Devic, E., Xiang, Y., Gould, D. & Kobilka, B. 2001. β-adrenergic receptor subtype-specific signaling in cardiac myocytes from β1 and β2 adrenoceptor knockout mice. Mol Pharmacol 60, 577-583.
40. Emorine, L.J., Marullo, S., Briend-Sutren, M.M., Patey, G., Tate, K., Delavier-Klutchko, C. & Strosberg, A.D. 1989. Molecular characterization of the human beta 3-adrenergic receptor. Science 245, 1118-1121.
41. Fan, J., Shuba, Y.M. & Morad, M. 1996. Regulation of cardiac sodium-calcium exchanger by beta-adrenergic agonists. Proc Natl Acad Sci USA 93, 5527-5532.
42. Farrell, A.P., MacLeod, K.R. & Chancey, B. 1986. Intrinsic mechanical properties of the perfused rainbow trout heart and the effects of catecholamines and extracellular calcium under control and acidotic conditions. J Exp Biol 125, 319-345.
43. Fischmeister, R. & Hartzell, H.C. 1987. Cyclic guanosine 3', 5'monophosphate regulates the calcium current in single cells from frog ventricle. J Physiol 387, 453-472.
44. Fischmeister, R., Castro, L.R., Abi-Gerges, A., Rochais, F., Jurevicious, J., Leroy, J. & Vandecasteele, G. 2006. Compartmentation of cyclic nucleotide signaling in the heart. The role of cyclic nucleotide phosphodiesterases. Circ Res 99, 816-828.
45. Fisher, M.H., Amend, A.M., Bach, T.J., Barker, J.M., Brady, E.J., Candelore, M.R., Carroll, D., Cascieri, M.A., Chiu, S.H., Deng, L. et al. 1998. A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J Clin Invest 101, 2387-2393.
46. Forster, M.E. 1976. Effects of adrenergic blocking drugs on the cardiovascular system of the eel, Anguilla anguilla (L.). Comp Biochem Physiol C 55, 33-36.
47. Forster, M.E. 1981. Effects of catecholamines on the hearts and ventral aortas of the eels Anguilla australis schmidtii and Anguilla dieffenbachii. Comp Biochem Physiol C 70, 85-90.
48. + ATPase mediated by oxidative signaling. Trends Cardiovasc Med 22, 83-87.
49. Gamperl, A.K., Wilkinson, M. & Boutilier, R.G. 1994. Beta adrenoreceptors in the trout (Oncorhynchus mykiss) heart: characterization, quantification, and effects of repeated catecholamine exposure. Gen Comp Endocrinol 95, 259-272.
50. Gattuso, A., Mazza, R., Pellegrino, D. & Tota, B. 1999. Endocardial endothelium mediates luminal ACh-NO signaling in isolated frog heart. Am J Physiol Heart Circ Physiol 276, H633-H641.
51. Gauthier, C., Tavernier, G., Charpentier, F., Langin, D. & Le Marec, H. 1996. Functional beta3-adrenoceptor in the human heart. J Clin Invest 98, 556-562.
52. Gauthier, C., Leblais, V., Kobzik, L., Trochu, J.N., Khandoudi, N., Bril, A., Balligand, J.L. & Le Marec, H. 1998. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102, 1377-1384.
53. Gauthier, C., Tavernier, G., Trochu, J.N., Leblais, V., Laurent, K., Langin, D., Escande, D. & Le Marec, H. 1999. Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists. J Pharmacol Exp Ther 290, 687-693.
54. Gauthier, C., Langin, D. & Balligand, J.L. 2000. Beta3-adrenoceptors in the cardiovascular system. Trends Pharmacol Sci 21, 426-431.
55. Gauthier, C., Rozec, B., Manoury, B. & Balligand, J.L. 2011. Beta-3 adrenoceptors as new therapeutic targets for cardiovascular pathologies. Curr Heart Fail Rep 8, 184-192.
56. Giltrow, E., Eccles, P.D., Hutchinson, T.H., Sumpter, J.P. & Rand-Weaver, M. 2011. Characterisation and expression of β1-, β2- and β3-adrenergic receptors in the fathead minnow (Pimephales promelas). Gen Comp Endocrinol 173, 483-490.
57. Graham, M.S. & Farrell, A.P. 1989. The effect of temperature acclimation and adrenaline on the performance of a perfused trout heart. Physiol Zool 62, 38-61.
58. Granneman, J.G., Lahners, K.N. & Rao, D.D. 1992. Rodent and human b3-adrenergic receptor genes contain an intron within the protein-coding block. Mol Pharmacol 42, 964-970.
59. Harding, S.E. 1997. Lack of evidence for β3-adrenoceptor modulation of contractile function in human ventricular myocytes [abstract]. Circulation 96, 284.
60. Hare, J.M., Kim, B., Flavahan, N.A., Ricker, K.M., Peng, X., Colman, L., Weiss, R.G. & Kass, D.A. 1998. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart. J Clin Invest 101, 1424-1431.
61. 2+ current in single heart cells. Nature 323, 273-275.
62. Hartzell, H.C., Mery, P.F., Fischmeister, R. & Szabo, G. 1991. Sympathetic regulation of cardiac calcium current is due exclusively to cAMP-dependent phosphorylation. Nature 351, 573-576.
63. Hoey, A.J., Jackson, C.M., Pegg, G.G. & Sillence, M.N. 1996. Characteristics of cyanopindolol analogues active at the beta 3-adrenoceptor in rat ileum. Br J Pharmacol 119, 564-568.
64. Holmgren, S. & Nilsson, S. 1982. Neuropharmacology of adrenergic neurons in teleost fish. Comp Biochem Physiol 72, 289-302.
65. Huggett, D.B., Khan, I.A., Foran, C.M. & Schlenk, D. 2003. Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. Environ Pollut 121, 199-205.
66. Huggett, D.B., Benson, W.H., Chipman, K., Cook, J.C., Grey, L.E., Kinter, L.B., Meyerhoff, R.D. & Trudeau, V.L. 2005. Role of mammalian data in determining pharmaceutical responses in aquatic species. In: R.T. Williams (ed.) Human Pharmaceuticals: Assessing the Impacts on Aquatic Ecosystems, pp. 149-181 (Chapter 5). Published SETAC Press, Pensacola, FL.
67. Hutchinson, D.S., Bengtsson, T., Evans, B.A. & Summers, R.J. 2002. Mouse beta 3a- and beta 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways. Br J Pharmacol 135, 1903-1914.
68. Imanishi, M., Tomishima, Y., Itou, S., Hamashima, H., Nakajima, Y., Washizuka, K., Sakurai, M., Matsui, S., Imamura, E., Ueshima, K. et al. 2008. Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human b3-Adrenergic receptor agonists with good oral bioavailability. Part I. J Med Chem 51, 1925-1944.
69. Imbrogno, S., Angelone, T., Adamo, C., Pulerà, E., Tota, B. & Cerra, M.C. 2006. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism. J Exp Biol 209, 4966-4973.
70. Imbrogno, S., Garofalo, F., Cerra, M.C., Mahata, S.K. & Tota, B. 2010. The catecholamine release-inhibitory peptide catestatin (chromogranin A344-363) modulates myocardial function in fish. J Exp Biol 213, 3636-3643.
71. Jurevicius, J., Skeberdis, V.A. & Fischmeister, R. 2003. Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2- adrenergic stimulation of ICa, L in frog ventricular myocytes. J Physiol 551, 239-252.
72. Kaumann, A.J. 1989. Is there a third heart beta-adrenoceptor? Trends Pharmacol Sci 10, 316-320.
73. Kaumann, A.J. & Molenaar, P. 1996. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Br J Pharmacol 118, 2085-2098.
74. Kaumann, A.J. & Molenaar, P. 1997. Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol 355, 667-681.
75. Kitamura, T., Onishi, K., Dohi, K., Okinaka, T., Isaka, N. & Nakano, T. 2000. The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart. J Cardiovasc Pharmacol 35, 786-790.
76. Kohout, T.A., Takaoka, H., McDonald, P.H., Perry, S.J., Mao, L., Lefkowitz, R.J. & Rockman, H.A. 2001. Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice. Circulation 104, 2485-2491.
77. Lands, A.M., Arnold, A., McAuliff, J.P., Luduena, F.P. & Brown, T.G. Jr 1967. Differentiation of receptor systems activated by sympathomimetic amines. Nature 214, 597-598.
78. Lelias, J.M., Kaghad, M., Rodriguez, M., Chalon, P., Bonnin, J., Dupre, I., Delpech, B., Bensaid, M., LeFur, G. & Ferrara, P. 1993. Molecular cloning of a human beta3-adrenergic receptor cDNA. FEBS Lett 324, 127-130.
79. Li, J., Yan, B., Huo, Z., Liu, Y., Xu, J., Sun, Y., Liu, Y., Liang, D., Peng, L., Zhang, Y., Zhou, Z.N., Shi, J., Cui, J. & Chen, Y.H. 2010. Beta2- but not beta1-adrenoceptor activation modulates intracellular oxygen availability. J Physiol 588, 2987-2998.
80. Loewi, O. 1921. Ubertragbarkeit der Herznervenwirkung. Pflugers Arch Gesamte Physiol 189, 239-242.
81. Lugnier, C., Gauthier, C., Le Bec, A. & Soustre, H. 1992. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities. Am J Physiol 262, H654-H660.
82. Maruyama, .I., Tatemichi, S., Goi, Y., Maruyama, K., Hoyano, Y., Yamazaki, Y. & Kusama, H. 2012. Effects of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, on bladder function in cynomolgus monkey. J Pharmacol Exp Ther 342, 163-168.
83. Mason, R.P., Jacob, R.F., Corbalan, J.J., Szczesny, D., Matysiak, K. & Malinski, T. 2013. The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells. BMC Pharmacol Toxicol 14, 48.
84. Masutani, S., Cheng, H.J., Morimoto, A., Hasegawa, H., Han, Q.H., Little, W.C. & Cheng, C.P. 2013. β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure. Am J Physiol Heart Circ Physiol 305, H923?H930.
85. Mattsson, C.L., Andersson, E.R. & Nedergaard, J. 2010. Differential involvement of caveolin-1 in brown adipocyte signaling: impaired beta3-adrenergic, but unaffected LPA, PDGF and EGF receptor signaling. Biochim Biophys Acta 1803, 983-989.
86. Mazza, R., Angelone, T., Pasqua, T. & Gattuso, A. 2010. Physiological evidence for β3-adrenoceptor in frog (Rana esculenta) heart. Gen Comp Endocrinol 169, 151-157.
87. McKenzie, D.J., Piccolella, M., Dalla Valle, A.Z., Taylor, E.W., Bolis, C.L. & Steffensen, J.F. 2003. Tolerance of chronic hypercapnia by the European eel Anguilla anguilla. J Exp Biol 206, 1717-1726.
88. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 88, 1197-1201.
89. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268, 26286-26295.
90. Méry, P.F., Pavoine, C., Pecker, F. & Fischmeister, R. 1995. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol Pharmacol 48, 121-130.
91. Miller, S.C., Gillis, T.E. & Wright, P.A. 2011. The ontogeny of regulatory control of the rainbow trout (Oncorhynchus mykiss) heart and how this is influenced by chronic hypoxia exposure. J Exp Biol 214, 2065-2072.
92. Moens, A.L., Takimoto, E., Tocchetti, C.G., Chakir, K., Bedja, D., Cormaci, G., Ketner, E.A., Majmudar, M., Gabrielson, K., Halushka, M.K. et al. 2008. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 117, 2626-2636.
93. Moens, A.L., Leyton-Mange, J.S., Niu, X., Yang, R., Cingolani, O., Arkenbout, E.K., Champion, H.C., Bedja, D., Gabrielson, K.L., Chen, J. et al. 2009. Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol 47, 576-585.
94. Moffett, S., Mouillac, B., Bonin, H. & Bouvier, M. 1993. Altered phosphorylation and desensitization patterns of a human beta2-adrenergic receptor lacking the palmitoylated Cys341. EMBO J 12, 349-356.
95. Molenaar, P., Sarsero, D. & Kaumann, A.J. 1997. Proposal for the interaction of non-conventional partial agonists and catecholamines with the 'putative beta 4-adrenoceptor' in mammalian heart. Clin Exp Pharmacol Physiol 24, 647-656.
96. Mongillo, M., Tocchetti, C.G., Terrin, A., Lissandron, V., Cheung, Y.F., Dostmann, W.R., Pozzan, T., Kass, D.A., Paolocci, N., Houslay, M.D. & Zaccolo, M. 2006. Compartmentalized phosphodiesterase-2 activity blunts b-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway. Circ Res 98, 226-234.
97. Moniotte, S. & Balligand, J.L. 2002. Potential use of beta(3)-adrenoceptor antagonists in heart failure therapy. Cardiovasc Drug Rev 20, 19-26.
98. Moniotte, S., Kobzik, L., Feron, O., Trochu, J.N., Gauthier, C. & Balligand, J.L. 2001. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103, 1649-1655.
99. Morimoto, A., Hasegawa, H., Cheng, H.J., Little, W.C. & Cheng, C.P. 2004. Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. Am J Physiol Heart Circ Physiol 286, H2425-H2433.
100. Myslivecek, J., Nováková, M., Palkovits, M., Krizanová, O. & Kvetnanský, R. 2006. Distribution of mRNA and binding sites of adrenoceptors and muscarinic receptors in the rat heart. Life Sci 79, 112-120.
101. Nantel, F., Bouvier, M., Strosberg, A.D. & Marullo, S. 1995. Functional effects of long-term activation on human beta 2- and beta 3-adrenoceptor signaling. Br J Pharmacol 114, 1045-1051.
102. Nickerson, J.G., Dugan, S.G., Drouin, G., Perry, S.F. & Moon, T.W. 2003. Activity of the unique beta-adrenergic Na+/H+ exchanger in trout erythrocytes is controlled by a novel beta3-AR subtype. Am J Physiol 285, 526-535.
103. Nilsson, S., Abrahamsson, T. & Grove, D.J. 1976. Sympathetic nervous control of adrenaline release from the head kidney of the cod, Gadus morhua. Comp Biochem Physiol 55, 123-127.
104. Niu, X., Watts, V.L., Cingolani, O.H., Sivakumaran, V., Leyton-Mange, J.S., Ellis, C.L., Miller, K.L., Vandegaer, K., Bedja, D., Gabrielson, K.L., Paolocci, N., Kass, D.A. & Barouch, L.A. 2012. Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. J Am Coll Cardiol 59, 1979-1987.
105. Owen, S.F., Giltrow, E., Huggett, D.B., Hutchinson, T.H., Saye, J., Winter, M.J. & Sumpter, J.P. 2007. Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish. Aquat Toxicol 82, 145-162.
106. Pennec, J.P. & Le Bras, Y.M. 1984. Storage and release of catecholamines by nervous endings in the isolated heart of the eel (Anguilla anguilla L.). Comp Biochem Physiol 77, 167-171.
107. Pennec, J.P. & Le Bras, Y.M. 1988. Diel and seasonal rhythms of the heart rate in the common eel (Anguilla anguilla L.): role of cardiac innervation. Exp Biol 47, 155-160.
108. Pérez-Schindler, J., Philp, A. & Hernandez-Cascales, J. 2013. Pathophysiological relevance of the cardiac β2-adrenergic receptor and its potential as a therapeutic target to improve cardiac function. Eur J Pharmacol 698, 39-47.
109. Perrone, M.G. & Scilimati, A. 2010. Beta3-Adrenoceptor agonists and (antagonists as) inverse agonists: history, perspective, constitutive activity, and stereospeci?c binding. In: P.M. Conn (ed.) Methods in Enzymology, Vol. 484, pp. 197-230. Academic Press, Burlington.
110. Petersen, L.H., Needham, S.L., Burleson, M.L., Overturf, M.D. & Huggett, D.B. 2013. Involvement of β(3)-adrenergic receptors in in vivo cardiovascular regulation in rainbow trout (Oncorhynchus mykiss). Comp Biochem Physiol A Mol Integr Physiol 164, 291-300.
111. Pietri-Rouxel, F. & Strosberg, A.D. 1995. Pharmacological characteristics and species-related variations of beta 3-adrenergic receptors. Fundam Clin Pharmacol 9, 211-218.
112. Pott, C., Brixius, K., Bloch, W., Ziskoven, C., Napp, A. & Schwinger, R.H. 2006. Beta3-adrenergic stimulation in the human heart: signal transduction, functional implications and therapeutic perspectives. Pharmazie 61, 255-260.
113. Randall, D.J. & Perry, S.F. 1992. The cardiovascular system. In: D.J. Randall & W.S. Hoar (eds) Fish Physiology, Vol. 12B, pp. 255-300. Academic Press, New York.
114. Rozec, B., Noireaud, J., Trochu, J.N. & Gauthier, C. 2003. Place of beta 3-adrenoceptors among other beta-adrenoceptor subtypes in the regulation of the cardiovascular system. Arch Mal Coeur Vaiss 96, 905-913.
115. Rozec, B., Quang, T.T., Noireaud, J. & Gauthier, C. 2006. Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta. Br J Pharmacol. 147, 699-706.
116. Rozec, B., Erfanian, M., Laurent, K., Trochu, J.N. & Gauthier, C. 2009. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart. J Am Coll Cardiol 53, 1532-1538.
117. Sandblom, E. & Axelsson, M. 2011. Autonomic control of circulation in fish: a comparative view. Auton Neurosci 165, 127-139.
118. Sato, M., Hutchinson, D.S., Bengtsson, T., Floren, A., Langel, U., Horinouchi, T., Evans, B.A. & Summers, R.J. 2005. Functional domains of the mouse beta3-adrenoceptor associated with differential G protein coupling. J Pharmacol Exp Ther 315, 1354-1361.
119. Sato, M., Hutchinson, D.S., Evans, B.A. & Summers, R.J. 2008. The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphen-oxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesul-fonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor. Mol Pharmacol 74, 1417-1428.
120. Sennit, M.V., Kaumann, A.J., Molenaar, P., Beeley, L.J., Young, P.W., Kelly, J., Chapman, H., Henson, S.M., Berg, J.M., Dean, D.K. et al. 1998. The contribution of classical (1/2-) and atypical -adrenoceptor to the stimulation of human white adipocyte lipolysis and right atrial appendace contraction by novel 3-adrenoceptors agonists of differing selectivities. J Pharmacol Exp Ther 285, 1084-1095.
121. Simmons, M.A. & Hartzell, H.C. 1998. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes. Mol Pharmacol 33, 664-671.
122. Skeberdis, V.A. 2004. Structure and function of beta3-adrenergic receptors. Medicina (Kaunas) 40, 407-413.
123. 2+ current. J Clin Invest 118, 3219-3227.
124. Smith, D.G. 1978. Neural regulation of blood pressure in rainbow trout (Salmo gairdneri). Can J Zool 56, 1678-1683.
125. Smith, D.G., Nilsson, S., Wahlqvist, I. & Eriksson, B.M. 1985. Nervous control of the blood pressure in the Atlantic cod, Gadus morhua. J Exp Biol 117, 335-347.
126. Soeder, K.J., Snedden, S.K., Cao, W., Della Rocca, G.J., Daniel, K.W., Luttrell, L.M. & Collins, S. 1999. The beta3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes. J Biol Chem 274, 12017-12022.
127. Staley, N.A. & Benson, E.S. 1968. The ultrastructure of frog ventricular cardiac muscle and its relationship to mechanisms of excitation-contraction coupling. J Cell Biol 38, 99-114.
128. Steinle, J.J., Booz, G.W., Meininger, C.J., Day, J.N. & Granger, H.J. 2003. Beta 3-adrenergic receptors regulate retinal endothelial cell migration and proliferation. J Biol Chem 278, 20681-20686.
129. Stene- Larsen, G. & Helle, K.B. 1978. Cardiac beta2-adrenoceptor in the frog. Comp Biochem Physiol 60C, 165-173.
130. Sterin-Borda, L., Bernabeo, G., Ganzinelli, S., Joensen, L. & Borda, E. 2006. Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response. J Mol Cell Cardiol 40, 580-588.
131. Strosberg, D. & Pietri-Rouxel, F. 1996. Function and regulation of the beta3-adrenoceptor. Trends Pharmacol Sci 17, 373-381.
132. 2+ current in rat ventricular myocytes. Circ Res 77, 803-812.
133. Summers, R.J., Broxton, N., Hutchinson, D.S. & Evans, B.A. 2004. The Janus faces of adrenoceptors: factors controlling the coupling of adrenoceptors to multiple signal transduction pathways. Clin Exp Pharmacol Physiol 31, 822-827.
134. Takimoto, E., Champion, H.C., Li, M., Ren, S., Rodriguez, E.R., Tavazzi, B., Lazzarino, G., Paolocci, N., Gabrielson, K.L., Wang, Y. & Kass, D.A. 2005. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 115, 1221-1231.
135. Taylor, E.W. 1992. The cardiovascular system. In: W.S. Hoar, D.J. Randall & A.P. Farrell, (eds) Fish Physiology, Vol. 12, pp. 343-387. Academic Press, San Diego.
136. Tota, B., Cerra, M.C. & Gattuso, A. 2010. Catecholamines, cardiac natriuretic peptides and chromogranin A: evolution and physiopathology of a 'whip-brake' system of the endocrine heart. J Exp Biol 213, 3081-3103.
137. Tran Quang, T., Rozec, B., Audigane, L. & Gauthier, C. 2009. Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta. Br J Pharmacol 156, 601-608.
138. Trochu, J.N., Leblais, V., Rautureau, Y., Bévérelli, F., Le Marec, H., Berdeaux, A. & Gauthier, C. 1999. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol 128, 69-76.
139. Ursino, M.G., Vasina, V., Raschi, E., Crema, F. & De Ponti, F. 2009. The beta3-adrenoceptor as a therapeutic target: current perspectives. Pharmacol Res 59, 221-234.
140. Vrydag, W. & Michel, M.C. 2007. Tools to study beta3-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 374, 385-398.
141. Wang, Z., Nishimura, Y., Shimada, Y., Umemoto, N., Hirano, M., Zang, L., Oka, O., Sakamoto, C., Kuroyanagi, J. & Tanaka, T. 2009. Zebrafish β-adrenergic receptor mRNA expression and control of pigmentation. Gene 446, 18-27.
142. Wheeldon, N.M., McDevitt, D.G. & Lipworth, B.J. 1994. Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man. Br J Clin Pharmacol 37, 363-369.
143. Woo, S.H. & Morad, M. 2001. Bimodal regulation of Na(+)-Ca(2+) exchanger by beta-adrenergic signaling pathway in shark ventricular myocytes. Proc Natl Acad Sci USA 98, 2023-2028.
144. 2+ current by beta3-adrenergic stimulation in failing rat heart. J Pharmacol Exp Ther 315, 1203-1211.
145. Zhang, X., Kan, Q., Fu, Y., Liu, S., Dai, Z. & Dong, Y. 2012. Noradrenergic activity regulated dexamethasone-induced increase of 5-HT(3) receptor-mediated glutamate release in the rat's prelimbic cortex. Biochim Biophys Acta 1823, 2157-2167.
146. Zhang, Z., Ding, L., Jin, Z., Gao, G., Li, H., Zhang, L., Zhang, L., Lu, X., Hu, L., Lu, B., Yu, X. & Hu, T. 2014. Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling. PLoS ONE 9, e98179.
147. Zhao, Q., Zeng, F., Liu, J.B., He, Y., Li, B., Jiang, Z.F., Wu, T.G. & Wang, L.X. 2013. Upregulation of β3-adrenergic receptor expression in the atrium of rats with chronic heart failure. J Cardiovasc Pharmacol Ther 18, 133-137.